Two-way ANOVA

3,202views

Two-way ANOVA

Revision for finals delete as I go

Revision for finals delete as I go

DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Thymus histology
Viral structure and functions
Wound healing
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Somatosensory pathways
Somatosensory receptors
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Nervous system anatomy and physiology
Muscle spindles and golgi tendon organs
Sciatica
Anatomy of the cranial meninges and dural venous sinuses
Anatomy of the blood supply to the brain
Anatomy of the abdominal viscera: Blood supply of the foregut, midgut and hindgut
Blood histology
Anatomy of the brainstem
Optic pathways and visual fields
Anatomy and physiology of the eye
Cerebral circulation
Stroke: Clinical
Cranial nerves
Cranial nerves rap
Cranial nerve pathways
Pharmacokinetics: Drug absorption and distribution
Anatomy of the basal ganglia
Basal ganglia: Direct and indirect pathway of movement
Cerebellum
Anatomy of the cerebellum
Auditory transduction and pathways
Vestibular transduction
Complement system
Dementia and delirium: Clinical
Substance misuse and addiction: Clinical
Tricyclic antidepressants
Typical antipsychotics
Metabolic alkalosis
Seizures and epilepsy
Free radicals and cellular injury
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Schizophrenia
Major depressive disorder
Bone remodeling and repair
Lambert-Eaton myasthenic syndrome
Pediatric orthopedic conditions: Clinical
Bone histology
Skin histology
Colon histology
Stomach histology
Cartilage histology
Ovary histology
Paget disease of bone
Non-steroidal anti-inflammatory drugs
Osteomalacia and rickets
Osgood-Schlatter disease (traction apophysitis)
Slipped capital femoral epiphysis
Developmental dysplasia of the hip
Rotator cuff tear
Thoracic outlet syndrome
Klumpke paralysis
Erb-Duchenne palsy
Carpal tunnel syndrome
Compartment syndrome
Osteomyelitis
Osteoporosis
Lordosis, kyphosis, and scoliosis
Osteoarthritis
Rheumatoid arthritis
Gout
Ankylosing spondylitis
Muscular dystrophy
Inclusion body myopathy
Dermatomyositis
Fibromyalgia
Myasthenia gravis
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Brachial plexus
Anatomy of the brachial plexus
Rheumatoid arthritis: Clinical
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Spearman's rank correlation coefficient
Mann-Whitney U test
Kappa coefficient
Chi-squared test
Fisher's exact test
Kaplan-Meier survival analysis
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Placebo effect and masking
Disease causality
Selection bias
Information bias
Confounding
Interaction
Bias in interpreting results of clinical studies
Bias in performing clinical studies
Prevention
Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Arteries and veins of the pelvis
Anatomy of the male reproductive organs of the pelvis
Nerves and lymphatics of the pelvis
Anatomy clinical correlates: Male pelvis and perineum
Anatomy of the breast
Anatomy of the female urogenital triangle
Anatomy clinical correlates: Breast
Development of the reproductive system
Prostate gland histology
Penis histology
Testis, ductus deferens, and seminal vesicle histology
Mammary gland histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the male reproductive system
Testosterone
Anatomy and physiology of the female reproductive system
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Stages of labor
Oxytocin and prolactin
Breastfeeding
Benign prostatic hyperplasia
Prostate cancer
Erectile dysfunction
Amenorrhea
Polycystic ovary syndrome
Premature ovarian failure
Endometritis
Endometriosis
Pelvic inflammatory disease
Preeclampsia & eclampsia
Placenta previa
Placental abruption
Potter sequence
Postpartum hemorrhage
Congenital cytomegalovirus (NORD)
Miscarriage
Ectopic pregnancy
Fetal alcohol syndrome
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Newborn management: Clinical
Neonatal jaundice: Clinical
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Resistance to blood flow
Compliance of blood vessels
Microcirculation and Starling forces
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac cycle
Cardiac work
Pressure-volume loops
Changes in pressure-volume loops
Action potentials in myocytes
Action potentials in pacemaker cells
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG normal sinus rhythm
ECG intervals
ECG axis
ECG rate and rhythm
ECG cardiac infarction and ischemia
ECG cardiac hypertrophy and enlargement
Baroreceptors
Chemoreceptors
ACE inhibitors, ARBs and direct renin inhibitors
Calcium channel blockers
Adrenergic antagonists: Beta blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Miscellaneous lipid-lowering medications
Positive inotropic medications
Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Kidney histology
Anatomy of the diaphragm
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Development of the respiratory system
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Alveolar gas equation
Diffusion-limited and perfusion-limited gas exchange
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Upper respiratory tract infection
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Chronic bronchitis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Pneumonia
Pancoast tumor
Pleural effusion
Pneumothorax
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Acromegaly
Pituitary adenomas and pituitary hyperfunction: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Miscellaneous protein synthesis inhibitors
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Antimalarials
Light microscopy and staining methods
Cardiac muscle histology
Artery and vein histology
Arteriole, venule and capillary histology
Pituitary gland histology
Pancreas histology
Eye and ear histology
Gallbladder histology
Esophagus histology
Small intestine histology
Liver histology
Spleen histology
Lymph node histology
Skeletal muscle histology
Ureter, bladder and urethra histology

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

USMLE® Step 2 style questions USMLE

0 of 1 complete

A cardiologist is studying the effects of gender and the type of statin prescribed on patients' low-density lipoprotein (LDL) levels. In particular, the study will assess the effects of atorvastatin, rosuvastatin, and pravastatin. 50 male and 50 female participants will be assigned to take each type of statin for six months. A table illustrating the study design is as follows:  

Table 1: Number of participants in each study group

Male
Female
Atorvastatin
5050
Rosuvastatin
5050
Pravastatin
5050

Afterwards, the LDL level for each participant is recorded. Which of the following statistical analyses should be performed to analyze the results of this study?  

Transcript

Watch video only

Content Reviewers

Contributors

Analysis of variance, or simply, ANOVA, is a type of parametric statistical test used to determine if there’s a significant difference between the means or averages of three or more groups.

And significance is normally defined by a p-value of less than 0.05 or 5%.

Now when doing any parametric test, there are three key assumptions that we have to make about the population.

First, the sample population must have been recruited randomly. Choosing names randomly ensures that the people included in the study will have similar characteristics to the target population. This is important because that ensures that the results of the t-test can be applied to the target population - meaning it has good external validity!

The second assumption is that each individual in the sample was recruited independently from other individuals in the sample. In other words, no individuals influenced whether or not any other individual was included in the study.

For example, if two friends decided to get their blood pressures measured on the same day, and they were both included in the study, these two individuals would not be independent of each other and the second assumption would not be met.

Like random sampling, independent recruitment of individuals is important because it ensures that the sample population approximates the target population.

The third assumption is that the sample size is large enough to approximate the target population, which usually means having more than 20 people.

If it’s impossible to get a large sample size, then the sample population must follow a normal bell-shaped distribution for the characteristic being studied because that’s what we would expect to see in the target population.

Okay, now let’s say there are three medications available for lowering systolic blood pressure, and you want to figure out if any of the medications work differently than the others. Additionally, you want to figure out if the medications work differently for males and females.

So, let’s say that you find 6 people - 3 males and 3 females - who take Medication A for 6 weeks, and that afterwards the mean systolic blood pressure is 130 mmHg for males and 125 mmHg for females. Then, you find another 3 males and 3 females who have been taking Medication B - and afterwards their mean systolic blood pressure is 138 for males and 126 for females, and finally you find 3 males and 3 females who have been taking Medication C - and afterwards their systolic blood pressure is 132 for males and 125 for females.

We can arrange the numbers in a table like this, with sex on the top and medication type on the side, and each cell represents a mean systolic blood pressure value.

To figure out if medication type and sex have an effect on systolic blood pressure, we can use an ANOVA test.

Specifically, we would use a two-way ANOVA test, because we are testing two factors - medication type and sex - that each have multiple groups within them.

There are three groups in the medication factor - which are A, B, and C - and we’ll use two groups for sex - male and female.

A two-way ANOVA test has six hypotheses. The first three are null hypotheses.

The first null hypothesis says that there’s no difference in systolic blood pressure for people taking different medication types.

The second null hypothesis says that there is no difference in systolic blood pressure for males and females.

The third null hypothesis says that there is no interaction between medication type and sex.

Interaction means that one factor influences the relationship between the second factor and the outcome. So, in this example, interaction would mean that the effect of medication on systolic blood pressure is different for males and females.

The alternate hypotheses are the opposite of the null hypotheses.

The first one says that there is a difference in systolic blood pressure for people taking different medication types; the second one says that there is a difference in systolic blood pressure for males and females; and the third one says that there is an interaction between medication type and sex.

Now, there are seven steps to test these hypotheses.

The first step is to calculate the mean of each factor, so the mean for all the medication types and the mean for both sexes.

To find the overall row mean systolic blood pressure for the medication A group, we add up the mean blood pressures for both males and females in that group, and divide by 2. So, 130 plus 125, divided by 2, is 127.5. We can do the same thing for the medication B and C groups. So, 138 plus 126, divided by 2, is 132. And 132 plus 125, divided by 2, is 128.5.

Finally, we can find the grand mean - which is the mean blood pressure measurements for all the medication groups - by adding up each row mean and dividing by 3. So 127.5 plus 132 plus 128.5, divided by 3, gives us a grand mean of 129.

To find the overall column means for the second factor, we add up the mean blood pressures in each medication group and divide by 3. So for males, 130 plus 138 plus 132, divided by 3, is 133.3. And for females, 125 plus 126 plus 125, divided by 3, equals 125.3. Notice that if we add up the column means for both sexes and divide by 2, it equals 129, which is the grand mean.

The second step is to find the total sum of squares, which tells you how much variation there is in the dependent variables. In other words, it compares every single individual in the study to the grand mean.

If the total sum of squares is large, it means that the individuals in the study, at every time point, are very spread out from one another; and if the total sum of squares is small, it means that the individuals in the study, at every time point, are clustered together.

To get the sum of squares, we start by subtracting the grand mean from each individual’s systolic blood pressure measurement, and then squaring it, which is called the squared difference. Then, we add up all the squared differences to get the total sum of squares. There are 18 people in this study, so we will have 18 squared differences, but to save time, let’s just do the first three.

The first person in the study is a female who took Medication A, and her systolic blood pressure is 124. So, we subtract the grand mean, which is 129, from 124, which equals negative 5. Then we square it, so 5-squared is 25. The second person is also a female who took Medication A, and her blood pressure is 126. So, 126 minus 129 is negative 3, squared, is 9. For the third person, who is also a female that took Medication A, we do 125 minus 129, which is negative 4, and then square it, which is 16. So, if we add up all of the squared differences for everyone in the study, we get a total sum of squares of 743.

The third step is to find the between-group variation, which is also called the sum of squares-between, or the SSB.

The sum of squares-between is a measure of how similar each group’s mean is to the grand mean. And, since we have two factors, we have to find the sum of squares-between for each factor and them add them together to get the total sum of squares-between.

To get the sum of squares-between for the medication factor, we start by subtracting the grand mean from each group’s row mean and squaring it, to get the squared difference. Then, we multiply the squared difference by the number of people in that group.

So, let’s start with the medication factor. For medication 1, the row mean is 127.5. So, the squared difference is 127.5 minus 129, squared, which is 2.25. Then, since there are 6 people in the medication group, we multiply 2.25 by 6, which equals 13.5. We do that same thing for the other two medication groups - so, 132 minus 129, squared, times 6, is 54; and 128.5 minus 129, squared, times 6, is 1.5. When we add up all the squared differences for all the medications, we get 13.5 plus 54 plus 1.5, which equals 69.

We do a similar process to get the sum of squares-between for the sex factor, but this time we use the column means.

For males, we subtract the grand mean from the column mean, then square it. So, 133.3 minus 129 is 4.3, and 4.3-squared is 18.5. Then we multiply it by the number of males in the study, which is 9, so 18.5 times 9 is 166.5. For females, the equation is the same, but we substitute in their column mean, which is 125.3. So 125.3 minus 129, squared, times 9, is 123. And when we add up both the sum of squares-between for males and females we get 289.5.

The fourth step in the ANOVA calculation is to find the within-group variation, which is also called the sum of squares-within, or SSW.

The sum of squares-within is a measure of how similar each individual blood pressure measurement is from its own group mean.

The sum of squares-within is sometimes called the sum of squared-error, because it’s the variation in systolic blood pressure that can’t be explained by either the different medication or the different sex, so it’s sort of this unexplained error in the blood pressure measurement. Basically, it’s the variation caused by individual characteristics, like age or genetic differences.

To find the sum of squares-within, we divide the individual blood pressure measurements into two tables - one for males and one for females. Now, let’s work with the male table first. For the sum of squares-within, you start by finding the squared differences for each person in one group, and to do this, you take each individual blood pressure measurement and subtract that group’s mean - which is the row mean - and then square it. For example, let’s just take the first 3 systolic blood pressure, which are the measurements in the Medication A group. So, it’s 122, 136, and 133. Since the row mean for Medication A is 130, you subtract 130 from each individual measurement, so 122 minus 130 is negative 8, 136 minus 130 is 6, and 133 minus 130 is 3. Then you square each number and add them all together to get the squared difference. So, when you add up negative 8-squared, or 64, and 6-squared, or 36, and 3-squared, or 9, you get 109.

Key Takeaways

Two-way ANOVA (Analysis of Variance) is a statistical method used to determine whether there are significant differences between two or more groups of data. It involves testing for two or more factors, or variables, that may influence the outcome of an experiment or study.

Two-way ANOVA allows for the examination of the main effects of each factor, as well as any interaction between the factors. The method calculates an F-value, which is then compared to a critical value to determine statistical significance. Two-way ANOVA is commonly used in various research fields, including medicine, psychology, and social sciences, to analyze data and test hypotheses.